JP2001057991A - Air permeable pasting agent and its production - Google Patents

Air permeable pasting agent and its production

Info

Publication number
JP2001057991A
JP2001057991A JP2000161183A JP2000161183A JP2001057991A JP 2001057991 A JP2001057991 A JP 2001057991A JP 2000161183 A JP2000161183 A JP 2000161183A JP 2000161183 A JP2000161183 A JP 2000161183A JP 2001057991 A JP2001057991 A JP 2001057991A
Authority
JP
Japan
Prior art keywords
plaster
patch
mesh
pasting agent
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000161183A
Other languages
Japanese (ja)
Inventor
Hidenobu Kawanami
秀信 川浪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yutoku Pharmaceutical Industries Co Ltd
Original Assignee
Yutoku Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yutoku Pharmaceutical Industries Co Ltd filed Critical Yutoku Pharmaceutical Industries Co Ltd
Priority to JP2000161183A priority Critical patent/JP2001057991A/en
Publication of JP2001057991A publication Critical patent/JP2001057991A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a pasting agent that has 'existence of uniform cells on the whole face of the pasting agent', 'sufficient adhesion as a pasting agent', 'plaster quantity that can secure necessary amount of medically effective components' and 'uniformity of applied plaster quantity' together, and to relieve hindrance of skin respiration and such cutaneous lesions as rash caused by stuffiness in conventional pasting agents. SOLUTION: This pasting agent with good air permeability is prepared by applying plaster 1 on a single face of an air permeable support 2 made from woven or nonwoven fabric using a rotary screen printing system so as to have clearances 3 in a pattern formed in netting or meshes with a size of 10 to 60 meshes. This serves relief of hindrance of cutaneous respiration or stuffiness and an air permeable pasting agent without lowering adhesion is obtained even when applied to such portions easily getting stuffy as the sole.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は通気性の優れた貼付
剤及びその製造法に関するもので、より詳細には、適用
した際に皮膚面の被覆によるかぶれ等の皮膚障害がきわ
めて少なく、かつ、発汗等が原因で起こるむれによる粘
着力の低下がない貼付剤及びその効率的な製造法に関す
るものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a patch having excellent air permeability and a method for producing the same. More particularly, the present invention relates to a skin patch such as a rash due to coating on the skin surface when applied, and The present invention relates to a patch which does not cause a decrease in adhesive strength due to unevenness caused by sweating or the like, and an efficient production method thereof.

【0002】[0002]

【従来の技術】皮膚に適用して薬効を発揮する貼付剤は
多数提供されているが、上記の通りかぶれ等の皮膚障害
を起こすおそれのあることが一般的に欠点となってい
る。皮膚障害を起こす原因の一つに皮膚呼吸の妨害やむ
れがあるが、貼付剤と皮膚との間に溜る皮膚からの蒸散
水分や汗により皮膚のむれが起こり、角質層中の起炎物
質がその水分中に溶け出し、炎症をひき起こすことが報
告されている。
2. Description of the Related Art Although a large number of patches have been provided which exert a medicinal effect when applied to the skin, as described above, there is a general drawback that skin patches such as rash may be caused. One of the causes of skin disorders is obstruction of skin respiration and unevenness.However, evaporative moisture or sweat from the skin that collects between the patch and the skin causes skin irregularity, and the inflammatory substances in the stratum corneum It has been reported to dissolve in the water and cause inflammation.

【0003】従来の通気性の低い貼付剤では、その他の
欠点として、特にむれやすい部位、例えば足の裏等へ貼
付した場合、経時的に接着力が低下し、容易に脱落する
場合があった。かといって膏体の粘着力を上げても、そ
れだけでは剥がれやめくれは解決せず、むれの抑制が必
要と考えられた。しかもこのような部位は角質層が厚
く、薬物を経皮的に吸収させるためには、多くの場合経
皮吸収促進剤が必要となるが、この経皮吸収促進剤が粘
着力をさらに低下させる要因となっていた。
Another drawback of the conventional patch having low air permeability is that, when the patch is applied to a part which is particularly easily peeled, for example, the sole of a foot, the adhesive strength decreases with time and the adhesive easily falls off. . However, increasing the adhesive strength of the plaster alone did not solve the peeling or turning over, and it was considered necessary to control the unevenness. Moreover, in such a site, the stratum corneum is thick and a transdermal absorption enhancer is often required in order to absorb the drug transdermally, but this transdermal absorption enhancer further reduces the adhesive force. Was a factor.

【0004】貼付剤による皮膚呼吸の妨害やむれを緩和
する技術として、通気性を得るために機械的に支持体か
ら膏体にかけて貫通した穴あけ加工をしたものがある。
しかし、穴あけ後の貼付剤強度が低下したり、あるいは
あけられた穴の部分の支持体と膏体が無駄になることか
ら、貼付剤全体に対するその穴が占める面積の割合は多
くとも1〜5%に止まり、従ってこの方法では十分な通
気性が得られなかった。
[0004] As a technique for alleviating the obstruction or irregularity of skin respiration caused by a patch, there is a technique of mechanically punching a hole from a support to a plaster to obtain air permeability.
However, since the strength of the patch after perforation is reduced or the support and the plaster at the portion of the perforated hole are wasted, the ratio of the area occupied by the hole to the entire patch is at most 1 to 5 %, And thus this method did not provide sufficient air permeability.

【0005】また、通気性支持体の片面に従来の膏体層
を施した貼付剤が通気性に優れているとされることがあ
るが、実際には膏体層自体がほとんど通気性を持たない
ため結局皮膚呼吸の妨害やむれは緩和されない。
In some cases, a patch having a conventional plaster layer provided on one side of a gas-permeable support has excellent air permeability, but in practice, the plaster layer itself has almost air permeability. As a result, obstruction and unevenness of skin respiration are not alleviated.

【0006】あるいは、特開昭63−203615号や
特開平1−297069号には、皮膚呼吸や発汗による
水分を吸収させるために、膏体に高吸水性高分子を配合
した技術が開示されているが、ある程度の水分の吸収は
望めても、水分を吸収して膨潤した高吸水性高分子が皮
膚に対する貼付剤の粘着力を低下させてしまうという欠
点があった。
[0006] Alternatively, JP-A-63-203615 and JP-A-1-297695 disclose a technique in which a highly water-absorbing polymer is blended into a plaster to absorb moisture due to skin respiration and perspiration. However, although a certain amount of water absorption can be expected, there is a disadvantage that the superabsorbent polymer that has absorbed water and swelled reduces the adhesive strength of the patch to the skin.

【0007】通気性支持体に多孔化された膏体層を施し
た貼付剤は通気性に優れ、皮膚呼吸の妨害やむれの緩和
に優れた効果が期待できる。従来から様々な貼付剤及び
その製造方法が報告されている。例えば、特公昭51−
10854号には、膏体の乾燥工程において膏体の収縮
により割れ目を生じさせたものが記載されているが、乾
燥効率が悪い、均一な気孔が得られない等の問題点があ
った。
[0007] A patch in which a porous layer is applied to a breathable support is excellent in breathability, and can be expected to have an excellent effect in preventing skin respiration and alleviating unevenness. Conventionally, various patches and methods for producing the same have been reported. For example,
Japanese Patent No. 10854 describes a method in which a crack is generated by shrinkage of the paste in the step of drying the paste, but has problems such as poor drying efficiency and uniform pores cannot be obtained.

【0008】また、特公昭62−14197号には膏体
に発泡剤を添加し膏体の発泡部にて通気性を出すものが
記載されているが、温度による発泡状態の変化、発泡に
よる粘着力低下の恐れがあった。
Japanese Patent Publication No. Sho 62-14197 discloses a method in which a foaming agent is added to a plaster to provide air permeability at a foaming portion of the plaster. There was a risk of weakness.

【0009】特公昭51−33811号には、膏体に気
泡あるいは液泡を分散させ、これらの気泡あるいは液泡
で通気性を出すものが記載されているが、気泡あるいは
液泡の分散された膏体の安定性に問題があった。
Japanese Patent Publication No. 51-33811 describes a method in which air bubbles or liquid bubbles are dispersed in a plaster, and the air bubbles are formed by the air bubbles or the liquid bubbles. There was a problem with stability.

【0010】特開昭56−2909号には、グラビアロ
ール法、オフセット印刷法、シルクスクリーン印刷法等
の印刷方式により膏体を多数の列状にあるいは網目状に
塗工する技術が開示されているが、グラビアロール法な
どのロール法による印刷塗工では、ロールによる加圧の
ために印刷される膏体が潰されて、前記膏体間の通気性
支持体表面が膏体で塞がるために良好な通気性が得られ
ないという問題点があった。また、シルクスクリーン印
刷法では連続生産ができず、コスト高になるという問題
点があった。
Japanese Patent Application Laid-Open No. 56-2909 discloses a technique in which plasters are applied in a number of rows or in a mesh by a printing method such as a gravure roll method, an offset printing method, and a silk screen printing method. However, in printing coating by a roll method such as a gravure roll method, the paste to be printed is crushed due to pressurization by the roll, and the air-permeable support surface between the pastes is closed by the paste. There was a problem that good air permeability could not be obtained. In addition, the silk screen printing method has a problem in that continuous production cannot be performed and the cost increases.

【0011】特開平11−33103号には、通気性基
材の一面に、密度0.93g/cm以下の低密度ポリ
エチレンが厚さ3〜10μmで積層されている積層基材
のポリエチレン積層面に、固形分10〜70重量%の粘
着剤の有機溶剤溶液を乾燥後の塗布量が5〜100g/
となるように塗布し、130〜200℃に加熱し、
乾燥させると共に上記低密度ポリエチレン層に無数の微
細な孔を形成させることを特徴とする通気性粘着テープ
の製造方法が記載されているが、粘着剤層には孔がない
ので、かぶれ等の皮膚障害を緩和するのに十分な通気性
は得られない。また、当該公報にはさらに、レーヨン繊
維及び/又はセルロース繊維を10〜100重量%含有
し、通気性基材に、該通気性基材重量100重量部に対
して0.5〜50重量部含水させた後、リバースコータ
ーを用いて固形分10〜70重量%の粘着剤の有機溶剤
溶液を乾燥後の塗布量が5〜100g/mとなるよう
に塗布し、130〜200℃に加熱し、乾燥させると共
に該粘着剤層に無数の微細な孔を形成させることを特徴
とする通気性粘着テープ製造方法が記載されているが、
形成される微細な孔が通気性基材の表面状態、乾燥温
度、粘着剤の粘性により左右されるので全面に均一な孔
を得ることは困難であった。また、無数の孔が形成され
た場合、その孔の占める面積の割合は必ずしも一定しな
いため粘着力等の物性がばらつく等の欠点があった。
Japanese Patent Application Laid-Open No. 11-33103 discloses a polyethylene laminated surface of a laminated base material in which low-density polyethylene having a density of 0.93 g / cm 3 or less is laminated on one surface of a gas permeable base material at a thickness of 3 to 10 μm. The coating amount after drying the organic solvent solution of the pressure-sensitive adhesive having a solid content of 10 to 70% by weight is 5 to 100 g /
m 2 and heated to 130-200 ° C.
A method for producing a breathable pressure-sensitive adhesive tape characterized by drying and forming a myriad of fine holes in the low-density polyethylene layer is described, but since the pressure-sensitive adhesive layer has no holes, skin such as rash Insufficient air permeability to mitigate the obstacle is not obtained. The publication further contains 10 to 100% by weight of rayon fiber and / or cellulose fiber, and the permeable base material contains 0.5 to 50 parts by weight of water per 100 parts by weight of the permeable base material. After that, an organic solvent solution of the adhesive having a solid content of 10 to 70% by weight was applied using a reverse coater so that the applied amount after drying was 5 to 100 g / m 2, and heated to 130 to 200 ° C. A method for producing a breathable pressure-sensitive adhesive tape, characterized by drying and forming an infinite number of fine holes in the pressure-sensitive adhesive layer,
It was difficult to obtain uniform pores over the entire surface because the fine pores formed depend on the surface condition of the air-permeable substrate, the drying temperature, and the viscosity of the adhesive. Further, when an infinite number of holes are formed, the ratio of the area occupied by the holes is not always constant, so that there is a disadvantage that physical properties such as adhesive strength vary.

【0012】上述のように、従来の通気性貼付剤及びそ
の製造方法には、貼付剤全面に均一な気孔が得られな
い、製造条件のコントロールが至難である、貼付剤とし
て必要な粘着性に欠ける、気孔が短時間で消失する、充
分な通気性が得られない、必要な膏体量(薬効成分量)
が塗布できない、連続生産ができない、工程が複雑であ
るなど多くの問題点が残されている。
As described above, the conventional air-permeable patch and the method for producing the same do not provide uniform pores over the entire surface of the patch, make it difficult to control the production conditions, and reduce the adhesiveness required for the patch. Chipping, pores disappear in a short time, sufficient air permeability cannot be obtained, required amount of plaster (amount of medicinal ingredient)
However, there are still many problems such as inability to apply, continuous production, and complicated processes.

【0013】[0013]

【発明が解決しようとする課題】本発明は上記従来技術
の持つ欠点を解決するため、「貼付剤の全面に均一な気
孔の存在」、「貼付剤としての充分な粘着性」、「必要
な薬効成分量を確保できる膏体量」及び「膏体塗工量の
均一性」を併せ持った貼付剤を提供し、従来の貼付剤に
あった皮膚呼吸の妨害やむれによるかぶれ等の皮膚障害
を緩和することが本発明の課題であり目的である。
SUMMARY OF THE INVENTION In order to solve the above-mentioned drawbacks of the prior art, the present invention is directed to "existence of uniform pores over the entire surface of the patch", "sufficient adhesiveness as a patch", We provide patches that combine the amount of plaster that can secure the amount of medicinal ingredients and the uniformity of the amount of plaster applied to prevent skin disorders such as obstruction of skin respiration and rash due to irregularities, which were present in conventional patches. Relaxation is an object and object of the present invention.

【0014】[0014]

【課題を解決するための手段】そこで、本発明者らは、
粘着技術及び多孔化技術に関し鋭意研究の結果、織布又
は不織布等の通気性支持体の片面に、膏体をロータリス
クリーン印刷方式で、網目の大きさが10〜60メッシ
ュの大きさになるように、網目状又は網目で構成される
パターン状に間隙を有して施すことで通気性の優れた貼
付剤を得るに至り、皮膚呼吸の妨害やむれが緩和された
通気性貼付剤を完成した。
Means for Solving the Problems Accordingly, the present inventors have:
As a result of earnest research on the adhesive technology and the porous technology, on one side of a breathable support such as a woven fabric or a nonwoven fabric, the paste is formed by rotary screen printing so that the mesh size becomes 10 to 60 mesh. In addition, a patch having excellent breathability was obtained by applying a gap having a mesh shape or a pattern composed of meshes, and a breathable patch was obtained in which interference with skin respiration and relief were reduced. .

【0015】また、その結果本発明の通気性貼付剤が、
発汗の多い場所あるいはむれやすい場所に長時間粘着が
可能となることも見出した。これは、特に足の裏への貼
付剤の適用(例:足白癬の治療等)を考えた場合、非常
に好都合な特性と考えられる。
As a result, the breathable patch of the present invention is
It has also been found that it is possible to stick for a long period of time in places where sweating is likely or where it is likely to be disturbed. This is considered to be a very advantageous property, especially when considering the application of the patch to the sole of the foot (eg treatment of tinea pedis, etc.).

【0016】本発明に使用する支持体は、通気性を有す
るものなら特に限定されず、織布、不織布などが使用で
きる。例えば、織布として綿、スフ、ナイロン、レーヨ
ン、ポリエステル、ポリプロピレンなどの繊維の織布が
用いられ、織り方、密度、繊維デニールなどは特に限定
されない。不織布としてレーヨン、セルロース、ナイロ
ン、ポリプロピレン、ポリエステルなどの繊維の単独又
はこれらの混抄品が用いられ、織り方、密度、繊維デニ
ールなどは特に限定されない。
The support used in the present invention is not particularly limited as long as it has air permeability, and a woven fabric, a nonwoven fabric and the like can be used. For example, a woven fabric of fibers such as cotton, woolen, nylon, rayon, polyester, and polypropylene is used as the woven fabric, and the weaving method, density, fiber denier, and the like are not particularly limited. As the nonwoven fabric, a single fiber of rayon, cellulose, nylon, polypropylene, polyester or the like or a mixture thereof is used, and the weaving method, density, fiber denier and the like are not particularly limited.

【0017】本発明の通気性貼付剤に使用する膏体の基
剤となる粘着剤は、油性粘着剤の中から適宜選択され
る。粘着剤の成分としては、スチレン−イソプレン−ス
チレンブロック共重合体、スチレン−ブタジエン−スチ
レンブロック共重合体、ポリアクリル酸エステル共重合
体、天然ゴム、各種合成ゴム等が挙げられ、粘着力など
粘着物性の必要に応じてテルペン系樹脂、脂肪族系合成
樹脂、ロジン系樹脂、ロジンエステル系樹脂などの粘着
付与剤や、流動パラフィン、ナフテン系オイル、ポリブ
テン、ポリイソブチレンなどの軟化剤や、酸化チタン、
酸化亜鉛などの充てん剤や、老化防止剤を配合してなる
ものが例示される。
The pressure-sensitive adhesive serving as the base of the plaster used in the breathable patch of the present invention is appropriately selected from oil-based pressure-sensitive adhesives. Examples of the component of the adhesive include styrene-isoprene-styrene block copolymer, styrene-butadiene-styrene block copolymer, polyacrylate copolymer, natural rubber, various synthetic rubbers, and the like. Tackifier such as terpene resin, aliphatic synthetic resin, rosin resin, rosin ester resin, softener such as liquid paraffin, naphthene oil, polybutene, polyisobutylene, and titanium oxide as needed ,
Examples thereof include fillers such as zinc oxide and those obtained by blending an antioxidant.

【0018】また、本発明の通気性貼付剤に使用するこ
とのできる薬効成分の代表例として下記のものが挙げら
れる。 コルチコステロイド類:例えばハイドロコルチゾン、プ
レドニゾロン、ベクロメタゾンプロピオネート、フルメ
タゾンなど、 鎮痛消炎剤:例えばアセトアミノフェノン、メフェナム
酸、フルフェナック酸、ジクロフェナックナトリウム、
サリチル酸、サリチル酸モノグリコール、1−メントー
ル、カンファーなど、 催眠鎮静剤:例えばフエノバルビタール、アモバルビタ
ール、トリアゾラムなど、 精神安定剤:例えばフルフエナジン、テオリタジン、ジ
アゼパム、クロルプロマジンなど、 抗高血圧剤:例えばクロニジン、ピンドロール、プロプ
ラノロール、ブプラノロールなど、 降圧利尿剤:例えばハイドロサイアザイド、ベンドロフ
ルナサイアザイドなど、 抗生物質:例えばペニシリン、テトラサイクリン、オキ
シテトラサイクリン、塩酸フラジオマイシンなど、 麻酔剤:例えばリドカイン、塩酸ジブカイン、ベンゾカ
イン、アミノ安息香酸エチルなど、 抗菌性物質:例えば塩化ベンザルコニウム、ニトロフラ
ゾン、アセトスルファミン、クロトリマゾール、トルナ
フテート、ビホナゾール、テルビナフィンなど、 ビタミン剤:例えばビタミンA、エルゴカルシフェロー
ル、リボフラビン酪酸エステルなど、 抗てんかん剤:例えばニトラゼパム、メプロバメート、
クロナゼパムなど、 冠血管拡張剤:例えばニトログリセリン、イソソルビド
ジナイトレート、ペンタエリスリトールテトラナイトレ
ートなど、 抗ヒスタミン剤:例えば塩酸ジフェンヒドラミン、クロ
ルフェニラミン、ジフェニルイミダゾールなど、 鎮咳剤:例えば硫酸サルブタモール、イソプロテレノー
ル、塩酸ツロブテロール、エフェドリンなど、 性ホルモン:例えばプロゲステロン、エストラジオール
など、 制吐剤:例えばスコポラミン、クレボプライド、5−フ
ルオロウラシル、メルカプトプリンなどが挙げられ、こ
れらの薬物は必要に応じて2種類以上併用できる。
The following are typical examples of medicinal ingredients that can be used in the breathable patch of the present invention. Corticosteroids: for example, hydrocortisone, prednisolone, beclomethasone propionate, flumethasone, etc. Analgesic and anti-inflammatory agents: for example, acetaminophenone, mefenamic acid, flufenac acid, diclofenac sodium,
Salicylic acid, monoglycol salicylate, 1-menthol, camphor, etc. Hypnotic sedatives: for example, phenobarbital, amobarbital, triazolam, etc. Mental stabilizers: for example, fluphenazine, theorytazine, diazepam, chlorpromazine, etc. Antihypertensive agents: for example, clonidine, pindolol , Propranolol, bupranolol, etc. Antihypertensive diuretics: for example, hydrothiazide, bendroflunathiazide, etc. Antibiotics: for example, penicillin, tetracycline, oxytetracycline, fradiomycin hydrochloride, etc. Anesthetics: for example, lidocaine, dibucaine hydrochloride, benzocaine, aminobenzoic acid Antibacterial substances such as ethyl: for example benzalkonium chloride, nitrofurazone, acetosulfamine, clotrimazole, tolnaphte Vitamins: for example, vitamin A, ergocalciferol, riboflavin butyrate, etc. Antiepileptic agents: for example, nitrazepam, meprobamate,
Clonazepam, etc. Coronary vasodilators: nitroglycerin, isosorbide dinitrate, pentaerythritol tetranitrate, etc. Antihistamines: diphenhydramine hydrochloride, chlorpheniramine, diphenylimidazole, etc. Antitussives: salbutamol sulfate, isoproterenol sulfate, tulobuterol hydrochloride , Ephedrine, etc. Sex hormones: for example, progesterone, estradiol, etc. Antiemetic agents: for example, scopolamine, crevopride, 5-fluorouracil, mercaptopurine, etc. These drugs can be used in combination of two or more as necessary.

【0019】また、本発明の通気性貼付剤には薬物の経
皮吸収性を向上させるために、エチレングリコール、ジ
エチレングリコールなどのグリコール類、オリーブ油、
ヒマシ油、ハッカ油などの油脂類などを吸収助剤として
配合してもよい。
The breathable patch of the present invention contains glycols such as ethylene glycol and diethylene glycol, olive oil,
Oils and fats such as castor oil and peppermint oil may be blended as an absorption aid.

【0020】本発明においては、膏体をロータリスクリ
ーン印刷方式を用いて施すことが特徴の一つであり、こ
れにより支持体及び膏体を無駄にすることなく、膏体を
通気性支持体に、網目状又は網目で構成されるパターン
状に間隙を有して連続的に施すことができる。ロータリ
シリンダにメッシュ加工される網目の大きさ及びパター
ンの形状で、膏体の網目の大きさ及び施される膏体量が
決定される。従って、必要に応じた大きさの網目及びパ
ターンの形状をロータリシリンダにメッシュ加工するこ
とで、貼付剤全面に均一な気孔の存在を確保でき、必要
量の膏体を均一に施すことができる。また、必要量の膏
体が均一に施されることで、貼付剤全面に必要量の薬効
成分が均一に確保できるとともに、貼付剤として充分な
粘着性も得られる。この時、網目の大きさを10〜60
メッシュとすることで、均一な塗工の場合、1平方メー
トル当たりの膏体塗工量を、一般の貼付剤(テープ剤)
に必要とされる膏体量200〜20gにすることができ
る。図1に、支持体に網目状に間隙を有して連続的に施
した膏体の状態をあらわした概略図を示す。
One of the features of the present invention is that the paste is applied by using a rotary screen printing method, so that the paste and the paste can be applied to the air-permeable support without wasting the support and the paste. It can be applied continuously with a gap in the form of a mesh or a pattern composed of meshes. The size of the mesh of the plaster and the amount of the plaster to be applied are determined by the size of the mesh and the shape of the pattern to be meshed on the rotary cylinder. Therefore, by meshing a mesh and a pattern having a size as required on the rotary cylinder, uniform pores can be ensured on the entire surface of the patch, and a required amount of plaster can be uniformly applied. In addition, since the required amount of the plaster is uniformly applied, the required amount of the medicinal component can be uniformly provided on the entire surface of the patch, and sufficient adhesiveness as the patch can be obtained. At this time, the size of the mesh is 10 to 60
In the case of uniform coating by using a mesh, the amount of plaster applied per square meter can be reduced by a general patch (tape).
The amount of plaster required for the above can be 200 to 20 g. FIG. 1 is a schematic diagram showing a state of a plaster continuously applied with a mesh-like gap on a support.

【0021】[0021]

【作用】本発明の貼付剤は優れた通気性を持ち、貼付に
よる皮膚呼吸の妨害やむれが著しく緩和される。その結
果、特に慢性疾患のように長期間の使用が必要な場合、
かぶれ等の皮膚障害の発生のため従来の貼付剤では困難
であった連続(反復)貼付を安全に行うことを可能とし
た。また、従来では容易に剥離してしまっていたむれや
すい場所、例えば足の裏や指等への貼付においても、長
時間にわたって安定に貼付させることを可能とした。さ
らに、ロータリスクリーン印刷方式を採用することよ
り、支持体及び膏体を無駄なく使用することが可能であ
る。以下に実施例を挙げ本発明をさらに具体的に説明す
る。
The patch of the present invention has excellent air permeability and remarkably relieves skin respiration and peeling caused by the patch. As a result, long-term use is necessary, especially for chronic diseases,
Continuous (repeated) patching, which was difficult with conventional patches due to the occurrence of skin disorders such as rashes, has been made possible safely. In addition, it has been possible to stably adhere to a place that is easily peeled off in the past, such as the sole of the foot or a finger, for a long time. Further, by employing the rotary screen printing method, the support and the plaster can be used without waste. Hereinafter, the present invention will be described more specifically with reference to examples.

【0022】[0022]

【実施例】(実施例1)粘着剤の原料としてスチレン−
イソプレン−スチレンブロック共重合体100重量部、
脂環族飽和炭化水素樹脂120重量部、流動パラフィン
40重量部を投入し、タンク温度を160℃に加熱し攪
拌した。原料を溶融・混合し粘着剤を得た。粘着剤を1
00℃に冷却後、サリチル酸グリコール20重量部、メ
ントール20重量部を加え充分攪拌して膏体を得た。得
られた膏体を、網目の大きさを16メッシュの四角形状
に加工したロータリシリンダが装着されたロータリスク
リーン印刷方式の塗工機を用い、通気性不織布の片面に
網目状に施し、その粘着面に剥離紙を貼り合わせ貼付剤
とした。得られた貼付剤は、1平方メートル当たりの膏
体量が120gであった。なお、膏体の皮膚への理論上
の接触面積は、全面塗工の場合の約50%となった。網
目状に施された膏体の配置を示した模式図を図2に示
す。
EXAMPLES (Example 1) Styrene was used as a raw material for an adhesive.
100 parts by weight of isoprene-styrene block copolymer,
120 parts by weight of an alicyclic saturated hydrocarbon resin and 40 parts by weight of liquid paraffin were charged, and the tank was heated to 160 ° C. and stirred. The raw materials were melted and mixed to obtain an adhesive. 1 adhesive
After cooling to 00 ° C., 20 parts by weight of glycol salicylate and 20 parts by weight of menthol were added and sufficiently stirred to obtain a plaster. Using a rotary screen printing type coating machine equipped with a rotary cylinder having a mesh size of 16 mesh square, the obtained plaster was applied to one side of a breathable nonwoven fabric in a mesh form, and the adhesive was applied. A release paper was stuck on the surface to give a patch. The obtained patch had a plaster weight of 120 g per square meter. In addition, the theoretical contact area of the plaster to the skin was about 50% of that in the case of the whole surface application. FIG. 2 is a schematic diagram showing the arrangement of the plasters applied in a mesh form.

【0023】(実施例2)ロータリシリンダの編目の大
きさが10メッシュであること以外は実施例1と同様に
して、本発明の貼付剤を得た。得られた貼付剤は、1平
方メートル当たりの膏体量が200gであった。
Example 2 A patch of the present invention was obtained in the same manner as in Example 1 except that the size of the stitch of the rotary cylinder was 10 mesh. The obtained patch had a plaster weight per square meter of 200 g.

【0024】(実施例3)ロータリシリンダの編目の大
きさが60メッシュであること以外は実施例1と同様に
して、本発明の貼付剤を得た。得られた貼付剤は、1平
方メートル当たりの膏体量が20gであった。
Example 3 A patch of the present invention was obtained in the same manner as in Example 1 except that the size of the stitch of the rotary cylinder was 60 mesh. The resulting patch had a plaster weight per square meter of 20 g.

【0025】(実施例4)ロータリシリンダの編目が円
形であること以外は実施例1と同様にして、本発明の貼
付剤を得た。網目状に施された膏体の配置を示した模式
図を図3に示す。
Example 4 A patch of the present invention was obtained in the same manner as in Example 1 except that the stitches of the rotary cylinder were circular. FIG. 3 is a schematic view showing the arrangement of the plasters formed in a mesh.

【0026】(実施例5)ロータリシリンダの編目が六
角形であること以外は実施例1と同様にして、本発明の
貼付剤を得た。網目状に施された膏体の配置を示した模
式図を図4に示す。
Example 5 A patch of the present invention was obtained in the same manner as in Example 1 except that the stitches of the rotary cylinder were hexagonal. FIG. 4 is a schematic diagram showing the arrangement of the plasters applied in a mesh form.

【0027】(実施例6)編目が五角形であり、それら
の集合パターンが筋状を形成するように加工したロータ
リシリンダを使用したこと以外は実施例1と同様にし
て、本発明の貼付剤を得た。網目状に施された膏体の配
置を示した模式図を図5に示す。
(Example 6) The patch of the present invention was prepared in the same manner as in Example 1 except that the stitches were pentagonal, and a rotary cylinder processed so that the aggregate pattern formed streaks was used. Obtained. FIG. 5 is a schematic diagram showing the arrangement of the plasters applied in a mesh.

【0028】(比較例1)実施例で得られた膏体を、ド
クターナイフコーターを用い、実施例と同じ不織布の片
面に、1平方メートル当たりの膏体量が120gになる
ように全面に施した。施された粘着面に剥離紙を貼り合
わせ貼付剤とした。
(Comparative Example 1) The plaster obtained in the example was applied to one surface of the same nonwoven fabric as in the example using a doctor knife coater so that the amount of plaster per square meter was 120 g. . A release paper was adhered to the applied adhesive surface to obtain a patch.

【0029】次に本発明の貼付剤を使用した場合の経皮
水分蒸散量及び対皮膚粘着力の試験結果を示し、本発明
の貼付剤の優れた通気性及び粘着性を明らかにする。
Next, the results of tests of the amount of transepidermal water evaporation and the adhesion to skin when the patch of the present invention is used are shown, and the excellent air permeability and adhesiveness of the patch of the present invention are clarified.

【0030】(試験例1)本試験は経皮水分蒸散量の測
定である。実施例1及び比較例1の貼付剤を前腕内側に
30分貼付し、貼付剤表面からの経皮水分蒸散量を測定
装置(引張り試験機)で測定した。コントロールとして
未貼付部からの経皮水分蒸散量を測定した。その結果を
図6に示す。図6から明らかな通り、膏体を網目状に施
した実施例1は、全面に施した比較例1と比較し、コン
トロール(未貼付部位)に近い経皮水分蒸散量を示し、
通気性がきわめて優れていることが確認された。
(Test Example 1) This test is a measurement of transepidermal water loss. The patches of Example 1 and Comparative Example 1 were stuck on the inner side of the forearm for 30 minutes, and the amount of transdermal water evaporation from the patch surface was measured with a measuring device (tensile tester). As a control, the transepidermal water loss from the unapplied part was measured. FIG. 6 shows the result. As is clear from FIG. 6, Example 1 in which the plaster was applied in a mesh form showed a transepidermal water loss close to that of the control (unapplied portion), as compared with Comparative Example 1 in which the plaster was applied to the entire surface.
It was confirmed that the air permeability was extremely excellent.

【0031】(試験例2)本試験は対皮膚粘着力の測定
である。実施例1及び比較例1の貼付剤をヒトの背中に
30分貼付し、その貼付剤を剥離する時の抵抗力を測定
装置(引張り試験機)で測定した(n=5)。その結果
を図7に示す。実施例1は比較例1の粘着面積の約50
%に過ぎないにもかかわらず、それと同等な対皮膚粘着
力を示した。
(Test Example 2) This test is a measurement of adhesion to skin. The patches of Example 1 and Comparative Example 1 were adhered to the back of a human for 30 minutes, and the resistance when the patches were peeled was measured with a measuring device (tensile testing machine) (n = 5). FIG. 7 shows the result. In Example 1, the adhesive area of Comparative Example 1 was about 50.
Despite being only%, it exhibited comparable skin adhesion to skin.

【0032】(試験例3)本試験は対皮膚粘着力の経時
変化の測定である。実施例1及び比較例1の貼付剤をヒ
トの足の裏に貼付し、各時間経過後にその貼付剤を剥離
する時の抵抗力を測定装置(引張り試験機)で測定した
(n=5)。その結果を図8に示す。比較例1の皮膚粘
着力は経時的に低下し、貼付24時間後には貼付部位よ
り剥がれていた。一方、実施例1は経時的な粘着力の低
下は認められず、24時間後においても十分な皮膚粘着
力を示した。
(Test Example 3) This test is a measurement of the change over time in the adhesive strength to skin. The adhesive patches of Example 1 and Comparative Example 1 were applied to the soles of human feet, and after each time, the adhesive force when peeling the adhesive patches was measured with a measuring device (tensile tester) (n = 5). . FIG. 8 shows the result. The skin adhesive strength of Comparative Example 1 decreased with time, and was peeled off from the application site 24 hours after application. On the other hand, in Example 1, no decrease in the adhesive force over time was observed, and sufficient adhesive force was exhibited even after 24 hours.

【0033】[0033]

【発明の効果】本発明の通気性貼付剤は、通気性支持体
に施された膏体が網目状に間隔をもって存在するため、
きわめて通気性に優れる。そのため、皮膚呼吸の妨害や
むれを緩和し、皮膚のむれが少なく、かぶれ等の皮膚障
害がきわめて少ない。従って、特に長期間繰り返し貼付
することが必要な慢性疾患患者等への使用に対しては非
常に好ましい貼付剤である。さらに、本発明の通気性貼
付剤は、むれやすい場所、例えば足の裏や指等への貼付
においても長時間にわたって安定に貼付することが可能
である。また、本発明の通気性貼付剤はロータリスクリ
ーン印刷方式によるため、膏薬や支持体原料のロスがな
く、通気性を発現させるための特別な工程も必要ないた
め、製造コストにおいても非常に優れている。
EFFECT OF THE INVENTION The air-permeable patch of the present invention is characterized in that the plasters applied to the air-permeable support are present in a mesh pattern at intervals.
Extremely breathable. Therefore, obstruction and unevenness of skin respiration are alleviated, skin unevenness is reduced, and skin disorders such as rash are extremely reduced. Therefore, it is a very preferable patch particularly for use in chronic disease patients and the like that need to be repeatedly patched for a long time. Further, the breathable patch of the present invention can be stably stuck for a long time even in a place where it is easily peeled, for example, a sole or a finger. Further, since the air-permeable patch of the present invention is based on the rotary screen printing method, there is no loss of plaster or raw material of the support, and there is no need for a special step for expressing air permeability, so that the production cost is extremely excellent. I have.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の通気性貼付剤の、膏体が支持体上に網
目状に施された様子を示す概略図である。
FIG. 1 is a schematic view showing a state in which a plaster of a breathable patch of the present invention is applied in a mesh on a support.

【図2】実施例1の網目状に施された膏体の配置を示し
た模式図である。
FIG. 2 is a schematic diagram showing the arrangement of the plasters applied in a mesh form in Example 1.

【図3】実施例4の網目状に施された膏体の配置を示し
た模式図である。
FIG. 3 is a schematic diagram showing an arrangement of a plaster applied in a mesh form in Example 4.

【図4】実施例5の網目状に施された膏体の配置を示し
た模式図である。
FIG. 4 is a schematic view showing an arrangement of a plaster body applied in a mesh form in Example 5.

【図5】実施例6の網目状に施された膏体の配置を示し
た模式図である。
FIG. 5 is a schematic view showing an arrangement of a plaster applied in a mesh form in Example 6.

【図6】実施例1及び比較例1の経皮水分蒸散量を示し
たグラフである。
FIG. 6 is a graph showing transepidermal water loss in Example 1 and Comparative Example 1.

【図7】実施例1及び比較例1の粘着力を示したグラフ
である。
FIG. 7 is a graph showing the adhesive strength of Example 1 and Comparative Example 1.

【図8】実施例1及び比較例1の粘着力の経時変化を示
したグラフである。
FIG. 8 is a graph showing the change over time in the adhesive strength of Example 1 and Comparative Example 1.

【符号の説明】[Explanation of symbols]

1 膏体 2 支持体 3 間隙 1 plaster 2 support 3 gap

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 通気性支持体の片面に施された膏体が網
目状に存在することを特徴とする通気性貼付剤。
1. A breathable patch, wherein the plaster applied to one surface of the breathable support is present in a mesh form.
【請求項2】 膏体が網目で構成されるパターン状に形
成されていることを特徴とする請求項1記載の通気性貼
付剤。
2. The breathable patch according to claim 1, wherein the plaster is formed in a pattern consisting of a mesh.
【請求項3】 膏体の網目の形状が、円形〜多角形状で
あることを特徴とする請求項1または請求項2記載の通
気性貼付剤。
3. The breathable patch according to claim 1, wherein the mesh of the plaster has a circular to polygonal shape.
【請求項4】 構成される網目のパターンが筋状に形成
されていることを特徴とする請求項1〜請求項3のいず
れかに記載の通気性貼付剤。
4. The air-permeable patch according to claim 1, wherein a pattern of the formed mesh is formed in a streak shape.
【請求項5】 膏体の網目の大きさが10〜60メッシ
ュであることを特徴とする請求項1〜請求項4のいずれ
かに記載の通気性貼付剤。
5. The breathable patch according to claim 1, wherein the mesh size of the plaster is 10 to 60 mesh.
【請求項6】 足の裏または足の指や趾間に使用するこ
とを特徴とする請求項1〜請求項5記載の通気性貼付
剤。
6. The breathable patch according to claim 1, which is used for the sole of the foot or between the toes or toes.
【請求項7】 ロータリスクリーン印刷方式により、通
気性支持体の片面に膏体を網目状又は網目で構成される
パターン状に施すことを特徴とする通気性貼付剤の製造
方法。
7. A method for producing a breathable patch, comprising applying a plaster on one surface of a breathable support in a mesh or a pattern constituted by a mesh by a rotary screen printing method.
JP2000161183A 1999-06-16 2000-04-21 Air permeable pasting agent and its production Pending JP2001057991A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000161183A JP2001057991A (en) 1999-06-16 2000-04-21 Air permeable pasting agent and its production

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11-208088 1999-06-16
JP20808899 1999-06-16
JP2000161183A JP2001057991A (en) 1999-06-16 2000-04-21 Air permeable pasting agent and its production

Publications (1)

Publication Number Publication Date
JP2001057991A true JP2001057991A (en) 2001-03-06

Family

ID=26516638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000161183A Pending JP2001057991A (en) 1999-06-16 2000-04-21 Air permeable pasting agent and its production

Country Status (1)

Country Link
JP (1) JP2001057991A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008272340A (en) * 2007-05-07 2008-11-13 Yasushi Ishida Tape for taping
WO2010048064A2 (en) * 2008-10-20 2010-04-29 The Brigham And Women's Hospital, Inc. Drug delivery system and its use in the treatment of postherpetic neuralgia

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008272340A (en) * 2007-05-07 2008-11-13 Yasushi Ishida Tape for taping
WO2008139816A1 (en) * 2007-05-07 2008-11-20 Yasushi Ishida Taping tape
WO2010048064A2 (en) * 2008-10-20 2010-04-29 The Brigham And Women's Hospital, Inc. Drug delivery system and its use in the treatment of postherpetic neuralgia
WO2010048064A3 (en) * 2008-10-20 2010-07-08 The Brigham And Women's Hospital, Inc. Drug delivery system and its use in the treatment of postherpetic neuralgia

Similar Documents

Publication Publication Date Title
US6465004B1 (en) Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
EP0464573B1 (en) Plaster high in softening substances
AT395815B (en) THERAPEUTIC DELIVERY SYSTEM FOR THE ADMINISTRATION OF AN ACTIVE SUBSTANCE THROUGH THE SKIN
EP1716850B1 (en) Transdermal plaster
EP0914820B1 (en) Plasters containing active agents having a partially applied adhesive composition
EP1121941B1 (en) Sorbefacients and preparations for percutaneous absorption containing the same
EP0787488A1 (en) Percutaneously absorbable patch
DE10212864B4 (en) Polymer matrices comprising a mixing system for solubilization of pharmaceutical agents, processes for their preparation and their use
WO2001052823A2 (en) Compositions to effect the release profile in the transdermal administration of drugs
JP2004174202A (en) Plaster
JP2006206471A (en) Tape preparation
KR20020011964A (en) Sheet-form adhesive preparation
EP1085914B1 (en) Plaster containing an active agent
EP1053030B1 (en) Supporting material for medicinal purposes
US20180235903A1 (en) Fentanyl Transdermal Delivery System
WO2006018340A1 (en) Active agent-containing plaster strip for treating joint diseases
WO1999036061A1 (en) Plasticizer and patch containing the plasticizer
EP1052979A1 (en) Device for releasing substances
US20190015352A1 (en) Applicators & Patches for Dermal & Transdermal Treatment Material & Drug Delivery, Methods of Making Them, & Methods of Use
JP2001057991A (en) Air permeable pasting agent and its production
JP3233732B2 (en) Method for producing breathable adhesive tape
JP4167750B2 (en) Transdermal absorption base and percutaneous absorption preparation containing the base
JPH06145050A (en) Production of patch
JPH09268123A (en) Cataplasm for local anesthesia
WO1998046267A1 (en) Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040713

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040903

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20051011